390 related articles for article (PubMed ID: 29775654)
1. Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context.
Bi J; Wu S; Zhang W; Mischel PS
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):76-87. PubMed ID: 29775654
[TBL] [Abstract][Full Text] [Related]
2. The landscape of metabolic pathway dependencies in cancer cell lines.
Joly JH; Chew BTL; Graham NA
PLoS Comput Biol; 2021 Apr; 17(4):e1008942. PubMed ID: 33872312
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Codependencies in the Tumor Microenvironment.
Dey P; Kimmelman AC; DePinho RA
Cancer Discov; 2021 May; 11(5):1067-1081. PubMed ID: 33504580
[TBL] [Abstract][Full Text] [Related]
4. Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape.
Rinaldi G; Rossi M; Fendt SM
Wiley Interdiscip Rev Syst Biol Med; 2018 Jan; 10(1):. PubMed ID: 28857478
[TBL] [Abstract][Full Text] [Related]
5. Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis.
Puccini J; Badgley MA; Bar-Sagi D
Trends Cancer; 2022 Jan; 8(1):54-64. PubMed ID: 34649835
[TBL] [Abstract][Full Text] [Related]
6. Profiling metabolic networks to study cancer metabolism.
Hiller K; Metallo CM
Curr Opin Biotechnol; 2013 Feb; 24(1):60-8. PubMed ID: 23206561
[TBL] [Abstract][Full Text] [Related]
7. Oncogene-directed alterations in cancer cell metabolism.
Nagarajan A; Malvi P; Wajapeyee N
Trends Cancer; 2016 Jul; 2(7):365-377. PubMed ID: 27822561
[TBL] [Abstract][Full Text] [Related]
8. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling.
Bi J; Ichu TA; Zanca C; Yang H; Zhang W; Gu Y; Chowdhry S; Reed A; Ikegami S; Turner KM; Zhang W; Villa GR; Wu S; Quehenberger O; Yong WH; Kornblum HI; Rich JN; Cloughesy TF; Cavenee WK; Furnari FB; Cravatt BF; Mischel PS
Cell Metab; 2019 Sep; 30(3):525-538.e8. PubMed ID: 31303424
[TBL] [Abstract][Full Text] [Related]
9. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations.
Choi H; Na KJ
Mol Cancer; 2018 Oct; 17(1):150. PubMed ID: 30333042
[TBL] [Abstract][Full Text] [Related]
11. Metabolic heterogeneity in cancer: An overview and therapeutic implications.
Tong Y; Gao WQ; Liu Y
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188421. PubMed ID: 32835766
[TBL] [Abstract][Full Text] [Related]
12. Targeting metabolic dependencies in pediatric cancer.
Issaq SH; Heske CM
Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
[TBL] [Abstract][Full Text] [Related]
13. Cancer metabolism in space and time: Beyond the Warburg effect.
Danhier P; Bański P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
[TBL] [Abstract][Full Text] [Related]
14. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
15. Cancer's insatiable appetite.
Locasale JW; Cantley LC; Vander Heiden MG
Nat Biotechnol; 2009 Oct; 27(10):916-7. PubMed ID: 19816448
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic regulation of tumor metabolic reprogramming.
Tarrado-Castellarnau M; de Atauri P; Cascante M
Oncotarget; 2016 Sep; 7(38):62726-62753. PubMed ID: 28040803
[TBL] [Abstract][Full Text] [Related]
17. Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers JR; Vander Heiden MG
Cancer Res; 2017 Jun; 77(12):3131-3134. PubMed ID: 28584183
[TBL] [Abstract][Full Text] [Related]
18. Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
Eason K; Sadanandam A
Cancer Res; 2016 Sep; 76(18):5195-200. PubMed ID: 27635042
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Dependencies in RAS-Driven Cancers.
Kimmelman AC
Clin Cancer Res; 2015 Apr; 21(8):1828-34. PubMed ID: 25878364
[TBL] [Abstract][Full Text] [Related]
20. Targeting metabolic vulnerabilities of cancer: Small molecule inhibitors in clinic.
Tripathi SC; Fahrmann JF; Vykoukal JV; Dennison JB; Hanash SM
Cancer Rep (Hoboken); 2019 Feb; 2(1):e1131. PubMed ID: 32721114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
